← Open Payments lookup

ANNISE CLAUDE: Open Payments

NPI 1295014330 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,083 in 83 payments from 22 companies in 2025. Trend: 2023 $2,743 · 2024 $1,869 · 2025 $2,083

Food & beverage: $1,983Education: $100
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation20$343
ABBVIE INC.7$191
PFIZER INC.10$144
Lilly USA, LLC6$138
Supernus Pharmaceuticals, Inc.1$138
Teva Pharmaceuticals USA, Inc.5$136
HARMONY BIOSCIENCES LLC2$131
Axsome Therapeutics, Inc.5$128
Lundbeck LLC5$126
Genentech USA, Inc.4$112

Products named: KESIMPTA, Qelbree, AUSTEDO XR, NURTEC ODT, VYEPTI, LEQEMBI, Ocrevus Zunovo, UBRELVY.

Industry payments across DC — which companies pay providers there.